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Transcriptional regulation
HoxHox genes play important roles in the speciﬁcation of spatial identity during development of vertebrate
embryos. Retinoic acid regulates the transcription of Hox genes in vertebrates. We identiﬁed an epidermal
enhancer in the 5′ ﬂanking region of an ortholog of Hox1 (Ci-Hox1) in the ascidian Ciona intestinalis. This
enhancer element drives the transcription of a lacZ reporter gene in the epidermis in the posterior trunk and
the anterior tail region of tailbud-stage embryos. Inhibition of retinoic acid synthesis resulted in inactivation
of the expression of the reporter gene. The enhancer contains a putative retinoic acid response element.
When this element was mutagenized, the expression of the reporter gene disappeared from the epidermis.
This sequence was also required for the response to exogenously administered retinoic acid. A heterodimeric
nuclear receptor, consisting of the retinoic acid receptor and retinoid X receptor, bound to this sequence.
These results indicate that retinoic acid directly activates the epidermal enhancer of Ci-Hox1. This is the ﬁrst
demonstration that retinoic acid is necessary for endogenous gene expression in ascidian embryos.
© 2009 Elsevier Inc. All rights reserved.Introduction
Animals belonging to the phylum Chordata are characterized by a
notochord, a dorsally located neural tube and a pharynx with gill slits
(Gee, 1996). Among chordates, ascidians, salps and larvaceans
comprise a unique sub-phylum, Urochordata. The body plan of their
tadpole-type larvae is greatly simpliﬁed but still retains the essence of
chordate-speciﬁc features (Satoh and Jeffery, 1995; Di Gregorio and
Levine, 1998). Therefore, urochordates are a suitable model system
with which to study the evolution of the molecular mechanisms that
establish the chordate-speciﬁc architecture of the body. Since retinoic
acid (RA) seems to play important developmental roles only in
chordates, it is proposed that the acquisition of RA-dependent
developmental programs was a key event during the evolution of
chordates (Fujiwara and Kawamura, 2003; Fujiwara, 2006).
RA is necessary formorphogenesis in vertebrate embryos. This was
clearly demonstrated by targeted mutagenesis of genes encoding
retinoic acid receptors (RARs) and a retinoic acid-synthesizing
enzyme, RALDH2 (Lohnes et al., 1994; Mendelsohn et al., 1994;
Niederreither et al., 1999). Particularly, RA regulates the formation of
chordate-speciﬁc organs and tissues, including the neural tube,
pharynx (branchial arches), paired limbs, and neural crest cells (for
reviews see Fujiwara and Kawamura, 2003; Campo-Paysaa et al.,
2008). RAR forms a heterodimer with retinoid X receptor (RXR), anda).
ll rights reserved.binds to a speciﬁc DNA sequence called the RA response element
(RARE) within the enhancer region of target genes (Umesono et al.,
1991; Bastien and Rochette-Egly, 2004). Hox genes are important
targets of RA signaling (Krumlauf et al., 1993; Marshall et al., 1996;
Altman and Brivanlou, 2001). Enhancer regions of Hox genes contain
RAREs and a normal expression depends on RA (Marshall et al., 1996).
Three major chordate groups (vertebrates, urochordates and cepha-
lochordates) possess RALDH2, RARs, and an RA-degrading cyto-
chrome P450 enzyme (CYP26) (Cañestro et al., 2006). Although genes
encoding these proteins have been found in lophotrochozoans
(mollusks and annelids), the morphogenetic role of RA seems
restricted to neurite outgrowth in these taxa (Campo-Paysaa et al.,
2008). Therefore, the connection of RAR to Hox enhancer elements
would have been a crucial event in the evolution of the chordate body
plan.
In cephalochordate embryos, exogenously administered RA inter-
fered with pharyngeal morphogenesis (Holland and Holland, 1996),
differentiation of epidermal neurons (Schubert et al., 2004a), and
patterning of the central nervous system (Schubert et al., 2006). An RA
antagonist had opposite effects, suggesting that endogenous RA
signaling is required for normal embryonic development (Schubert et
al., 2004a,b, 2006). Hox1 plays a key role in mediating the actions of
RA in most of these cases (Schubert et al., 2004b, 2006). The
amphioxus Hox1 gene (AmphiHox-1) contains a functional RA
response element (RARE) within its enhancer located in the 3′
ﬂanking region (Manzanares et al., 2000; Wada et al., 2006). The
AmphiHox-1 enhancer directs reporter gene expression in the
hindbrain and neural crest cells in embryos of chicks and mice
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revealed that cephalochordates diverged earlier during the evolution
of chordates, and urochordates are the closest relatives of vertebrates
(Delsuc et al., 2006, 2008). Therefore, the pivotal role of RA in
cephalochordates indicates that hard wiring of the RAR-Hox regula-
torymachinery had already been established in the common chordate
ancestor.
In contrast to the case in cephalochordates, RA does not have
a severe effect on morphogenesis in the embryo of the larvacean
Oikopleura dioica, which belongs to the urochordates (Cañestro and
Postlethwait, 2007). RA did not affect the expression pattern of Hox1
or any other gene examined (Cañestro and Postlethwait, 2007). The
compact genome of this species does not contain Raldh2, RAR, andFig. 1. Characterization of an epidermal enhancer of Ci-Hox1. (A) The genomic structure of th
indicated by an arrow. The putative translation initiation site is indicated by an arrowhead. R
SpeI; Xh, XhoI; Xm, XmnI. A part of the second intron, colored in red, was used for construc
containing the 5′ ﬂanking region and a fragment of intron 2 of Ci-Hox1. Names of transgenes
created by SalI and XhoI is indicated (Sa/Xh). The junction between the blunt ends created b
visualized by the histochemical staining of β-galactosidase activity. The β-galactosidase w
oriented to the left, with the dorsal side up. ep, epidermis; nt, neural tube. Insets show sim
carrying Ci-Hox1(intron2)/lacZ. (D) DMSO-treated control embryos carrying Ci-Hox1(intro
embryos carrying Ci-Hox1(ΔBsSp)/lacZ. (G) RA-treated embryos carrying Ci-Hox1(ΔBsSp)/lCyp26 (Cañestro et al., 2006). Thus, Cañestro and Postlethwait
(2007) proposed that the regulatory input from RAR to Hox was
disconnected early on in the evolution of the urochordate lineage.
The urochordate ascidian Ciona intestinalis is an emerging model
system for studying embryonic development (Satoh, 2003). In this
species, exogenously administered RA enhances the expression of a
variety of genes, including Ci-Hox1 (Ishibashi et al., 2003, 2005;
Nagatomo et al., 2003). Therefore, the RA signaling machinery is
highly active in the C. intestinalis embryo, unlike the O. dioica embryo.
The C. intestinalis genome contains a single Hox1 gene, named Ci-
Hox1 (Dehal et al., 2002; Ikuta et al., 2004). Ci-Hox1 is expressed
around the neck region and visceral ganglion of the nerve cord and in
a restricted area of the epidermis (Nagatomo and Fujiwara, 2003;e Ci-Hox1 gene. Exons are indicated by gray boxes. The putative transcription start site is
ecognition sites of restriction enzymes are also indicated. Nc, NcoI; Nr, NruI; Sa, SalI; Sp,
ting the reporter constructs shown in (B). (B) Diagrams show the reporter constructs
are on the right. The intronic sequence is in red. The junction between the cohesive ends
y XmnI and NruI is also indicated (Xm/Nr). (C-G) The expression pattern of transgenes,
as immunologically detected in (C'). In all panels, the anterior side of the embryo is
ilar expression patterns observed in multiple specimens. (C and C') Normal embryos
n2)/lacZ. (E) RA-treated embryos carrying Ci-Hox1(intron2)/lacZ. (F) DMSO-treated
acZ.
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epidermal Ci-Hox1 expression domain encompasses the posterior
trunk to the anterior tail (Nagatomo and Fujiwara, 2003). RA
treatment activates Ci-Hox1 expression in the entire epidermis
(Nagatomo and Fujiwara, 2003). A microarray analysis revealed that
the RA-induced activation occurred in the absence of translation,
suggesting that pre-existing RAR directly activates the enhancer of
Ci-Hox1 (Ishibashi et al., 2005). Knockdown of Raldh2 using a speciﬁc
morpholino oligonucleotide diminished the expression of Ci-Hox1,
indicating that endogenous RA is essential for the Ci-Hox1 expression
(Imai et al., 2009). Despite the circumstantial evidence, no RARE has
ever been identiﬁed in the enhancer regions of Ci-Hox1 or other
targets in C. intestinalis. It has been unclear whether the expression of
these genes requires the endogenous RA signal in normal embryos.
In the present study, we identiﬁed an epidermal enhancer of Ci-
Hox1within the 5′ ﬂanking region.We demonstrated that the Ci-RAR/
Ci-RXR heterodimer binds to an RARE found in the enhancer. Muta-
tion of this RARE diminished Ci-Hox1 expression in the epidermis,
suggesting that RAR-mediated RA signaling directly activates Ci-Hox1
expression in the epidermis of normal C. intestinalis embryos.
Materials and methods
Animals
C. intestinalis juvenile adults were kindly provided by Kazuko
Hirayama and Nori Satoh at Kyoto University, through the National
Bio-Resource Project of MEXT, Japan. They were cultured in Tosa Bay
near the Usa Marine Biological Institute. Eggs and sperm were
surgically obtained from the gonoducts. Eggs were inseminated with
non-self sperm. Fertilized eggs were dechorionated with 0.05%
actinase E (Kaken Pharm., Tokyo, Japan) and 1% sodium thioglycolate.
The embryos were raised in agarose-coated Petri dishes.
Transgenes
Genomic DNA corresponding to the 5′ ﬂanking region of Ci-Hox1
was ampliﬁed by polymerase chain reaction (PCR) using the primers
1.0F (5′-TAGATTGATGATTCAATATGAGGAACGTAATTTCG-3′) and 1.0R
(5′-ACCGGGTATTCTAGATACGAATTCATCTTACACCT-3′). The italicized
sequence in 1.0R corresponds to the translation initiation site located
within the second exon (Fig. 1A). The PCR product was inserted into
pGEM-T (Promega, Madison, WI), and then excised with XhoI and
XbaI. The recognition site of XhoI was located within the 5′ ﬂanking
sequence (Fig. 1A), while that of XbaI was the underlined sequence in
1.0R. This DNA fragment was inserted into the vector pSP72-1.27
(Corbo et al., 1997) digested with XhoI and XbaI. The resulting
plasmid was named Ci-Hox1(1.0)/lacZ. The second intron of Ci-Hox1
was ampliﬁed by PCR, using 5′-CACCGGCTAGCAGTAAGTTGTAAAGTT-
TAACA-3′ and 5′-CCATACCCGGGACTAAAACAGACACAAAACATTGT-3′.
The product of the PCR was inserted into pGEM-T. A 1.9-kb central
region of the intron was excised with SalI and XmnI, the recognition
sites of which were located within the intronic sequence (Fig. 1A).
This fragment was then inserted into Ci-Hox(1.0)/lacZ digested with
XhoI and NruI, whose recognition sites were located within the 5′
ﬂanking region (Fig. 1A). The resultant plasmid was called Ci-Hox1
(intron2)/lacZ. Ci-Hox1(intron2)/lacZ was digested with BstBI and
SpeI (Fig. 1A). Cohesive ends created by these enzymes were blunted,
using T4 DNA polymerase, and the circular plasmid was recovered by
self-ligation. The resultant plasmid was called Ci-Hox1(ΔBsSp)/lacZ.
For site-directed mutagenesis, the NcoI–SpeI fragment in Ci-Hox1
(intron2)/lacZ was mutagenized as follows (see Figs 1A and 5A). A
DNA fragment was ampliﬁed by PCR using 5′-GTTTTGCTCCC-
ATGGCCTCGATC-3′ (NcoI site is underlined) and 5′-GGTGAAAAtcTa-
gaCGTTTGT-3′ (XbaI site is underlined). The lower case letters in the
latter primer were not complementary to the native Ci-Hox1sequence. The product of the PCR was inserted into pGEM-T. This
plasmid was named Mut-X. Another DNA fragment was ampliﬁed by
PCR using 5′-ACAAACGgctAgCTTTTCACC-3′ (NheI site is underlined)
and 5′-CTTTACCTACTAGTATAAAGC-3′ (SpeI site is underlined). The
lower case letters in the former primer were not complementary to
the native Ci-Hox1 sequence. The product of the PCR was once
inserted into pGEM-T, and then cut withNheI and SpeI. This restriction
fragment was inserted into Mut-X digested with XbaI and SpeI. In this
case, SpeI cut its recognition site within the vector sequence. The
cohesive ends produced by NheI and XbaI were ligated. As a result, the
putative RARE sequence, 5′-ATGAACTTTTCACCC-3′ (underlines show
putative binding sites for RAR and RXR), was mutagenized into 5′-
GCTAGATTTTCACC-3′ (underline shows the NheI/XbaI junction).
After conﬁrmation of the sequence, the mutagenized enhancer was
excised from Mut-RARE with NcoI and SpeI, and replaced with the
corresponding wild-type enhancer fragment in Ci-Hox1(intron2)/
lacZ.
For construction of Ci-Hox1(0.9)/lacZ, genomic DNA corresponding
to the 5′ ﬂanking region of Ci-Hox1 was ampliﬁed by PCR using the
primers 0.9F (5′-GGGGTCGACGAACGATCATCATGCCAACAT-3′) and
0.9R (5′-GGGGATCCTGCGGGGTGATGTGGTTGGTAT-3′). The ampliﬁed
DNA fragmentwas digestedwith SalI andBamHI (underlined sequences
in 0.9F and 0.9R, respectively) and inserted into pSP72-1.27. For
construction of Ci-Hox1(del1)/lacZ, two different parts of the Ci-Hox1 5′
ﬂanking region were separately ampliﬁed by PCR. The primers used
were0.9F and0.9-del1-R (5′-GGGTCTAGATCCAATTTTAATATAAGAAAC-
3′) for the 5′ fragment, and 0.9-del1-F (5′-GGGTCTAGATGTGACCGGA-
CACTGGAAACA-3′) and 0.9R for the 3′ fragment. The recognition sites of
XbaI are underlined. The 5′ fragment was digested with SalI and XbaI,
while the 3′ fragment was digested with XbaI and BamHI. These
fragments were inserted one by one into pSP72-1.27. As a result, a
conserved sequence (element 1; see Figs. 4B, C) in the 5′ ﬂanking region
of Ci-Hox1 was replaced by the recognition site of XbaI. Ci-Hox1(del2)/
lacZ was constructed by a similar method, except that the primers 0.9-
del-2R (5′-GGTCTAGAGCTTTCGGCGCGTTTCTCATTT-3′) and 0.9-del2-F
(5′-GGTCTAGAGCTGTTTTTACAAGATGAATAA-3′) were used instead of
0.9-del1-R and 0.9-del1-F, respectively. As a result, another conserved
sequence (element 2; see Figs. 4B, C) was replaced by the recognition
site of XbaI. Ci-Hox1(0.9)mut/lacZ was also made by a similar method,
except that mutF (5′-GGGGCTAGCTTTTCACCCTAGAGTGAAGAC-3′) and
mutR (5′-GGGTCTAGACGTTTGTTTGCTTATTATCTT-3′) were used in-
stead of 0.9-del1-F and 0.9-del1-R, respectively. In this case, mutF
contained the recognition sequence of NheI, while mutR contained the
recognition sequence of XbaI. Both of the DNA fragments were inserted
into pSP72-1.27, where cohesive ends produced by NheI and XbaI were
ligated. In this construct, a DR2-type RARE (5′-TGAACTTTTCACCC-3′)
was replaced by the sequence (5′-ctagCTTTTCACCC-3′) (see Figs. 4B–D).
Electroporation, drug administration, and detection of the expression of
reporter genes
A large-scale preparation of plasmid DNA was carried out using
QIAGEN tip-100 (QIAGEN, Valencia, CA). The plasmid DNA was
dissolved in 500 μl of 0.77 M mannitol at a concentration of 60 μg/ml.
The plasmid DNA was introduced into dechorionated embryos by
electroporation as described by Corbo et al. (1997).
Electroporated embryos were treated with 1 μM all-trans RA
(Sigma-Aldrich, St. Louis, MO) in the presence or absence of 200 μg/
ml of puromycin (Sigma-Aldrich) for 1 h from the neurula stage. As a
control, embryos were treated with 0.1% dimethylsulfoxide (DMSO),
since the 1 mM RA stock was dissolved in DMSO. To inhibit RA
synthesis, embryos were treated with 3,7-dimethyl-2,6-octadienal
(citral) or 4-dimethylaminobenzaldehyde (DEAB) from the 32-cell
stage to the middle tail bud stage. As a control, embryos were treated
with 0.1% DMSO or 0.1% ethanol, since the DEAB and citral stockswere
dissolved in DMSO and in ethanol, respectively.
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containing 4% paraformaldehyde, 100mMMOPS (pH 7.5) and 500mM
NaCl. Whole-mount in situ hybridization was performed essentially
according to Mita and Fujiwara (2007), except that the immunological
detection of hybridization signals was carried out using a buffer
containing 100 mM Tris–HCl (pH 7.5) and 150 mM NaCl, instead of
phosphate-buffered saline. For the detectionofβ-galactosidase activity,
embryos were ﬁxedwith 0.75% formaldehyde at room temperature for
30min. The specimens were stained in seawater containing 120 μg/ml
of X-gal, 3 mM potassium ferrocyanide, 3 mM potassium ferricyanide,
1 mM MgCl2, 0.1% Tween20, and 0.75% formaldhyde. For immunolo-
gical detection of β-galactosidase, embryos were ﬁxed with 3.5%
formaldehyde at 4 °C for 3 h. The specimens were washed with
phosphate-buffered saline containing 0.1% Triton X-100 (T-PBS), and
were incubated at room temperature for 3 h in T-PBS containing 10%
goat serum (Vector Laboratories, Burlingame, CA). The specimenswere
reacted with a monoclonal anti-β-galactosidase antibody (Promega)
overnight at 4 °C. After washing with T-PBS, the specimens were
stained with an Alexa488-conjugated anti-mouse IgG raised in goat
(Molecular probes-Invitrogen, Tokyo, Japan). Fluorescent images were
obtained using a C1si confocal microscope (Nikon, Tokyo, Japan).
Electrophoretic mobility shift assay (EMSA)
The entire translated region of Ci-RAR and Ci-RXR was obtained by
PCR using KOD DNA polymerase (Toyobo, Osaka, Japan) and cDNA
clones (ID citb035d16 and citb010c11, respectively) as templates
(Satou et al., 2002). The primers used for the ampliﬁcation of Ci-RAR
were AF (5′-TGAACGTTATGGAGTTTCAAGAACA-3′) and AR (5′-
ACGAGGCTAGCTTATTCGACCTCGT-3′), while those for Ci-RXR were
XF (5′-CATTGCCAACTACGGGGAATGGTTT-3′) and XR (5′-CAGTGGC-
TAGCTCACAGGTTGGCGA-3′). Italicized sequences in AR and XR
correspond to stop codons. The recognition site of NheI is underlined.
Theproducts of the PCRwere digestedwithNheI. TheseDNA fragments
were inserted into pCMX-hRARα (Umesono et al., 1991) digestedwith
MscI and NheI. The resultant plasmids were named pCMX-Ci-RAR and
pCMX-Ci-RXR, respectively. Using these plasmids as templates, the Ci-
RAR and Ci-RXR proteins were produced, according to the protocol for
the TNT-coupled Reticulocyte Lysate Systems (Promega).
The double-stranded DNA probe, named Ci-Hox1-DR2, was
prepared by annealing the complementary oligonucleotides, 5′-
AACAAACGATGAACTTTTCACCCTAGAGTG-3′ and 5′-TTCACTCTAGGGT-
GAAAAGTTCATCGTTTG-3′, where sequences corresponding to a puta-
tive RARE are underlined. The probe, named Ci-Hox1-DR2mut, was
prepared by annealing the oligonucleotides, 5′-AACAAACGtcta-
gCTTTTCACCCTAGAGTG-3′ and 5′-TTCACTCTAGGGTGAAAAGcta-
gaCGTTTG-3′. Lower case letters indicate mutagenized sites. The 5′
end of both strands was labeled with a Redivue [γ-32P] adenosine
triphosphate (GE healthcare, Buckinghamshire, UK). In vitro translated
proteins and labeled double-stranded DNA probes were incubated in a
binding buffer for 20 min at room temperature. The binding buffer
contained 10 mM Tris–HCl (pH 7.5), 50 mM NaCl, 0.5 mM DTT, 4%
glycerol, 0.5 mM EDTA, 1 mMMgCl2, 0.05 mg/ml of poly (dI–dC)Upoly
(dI–dC), 0.5 mM ZnCl2, and 0.2 μM all-trans retinoic acid. A 50-fold
excess of unlabeled competitorDNAwasadded to the reactionbuffer. As
a non-speciﬁc competitor, the AP2 oligonucleotide supplied in the Gel
Shift Assay System (Promega) was used. The autoradiogram was
obtained using a BAS-2500 IP Reader (Fujiﬁlm, Tokyo, Japan).
Results
An epidermal enhancer of Ci-Hox1 is located within the 5′ ﬂanking
region
The C. intestinalis genome contains a single Hox1 gene (Ikuta et al.,
2004). The Ci-Hox1 gene consists of four exons (Fig. 1A). A putativetranslation initiation site is located within the second exon (Fig. 1A).
The nucleotide sequence of Ci-Hox1 was compared with that of the
ortholog of Hox1 in a related ascidian species, Ciona savignyi, using the
VISTA Genome Browser (http://genome.lbl.gov/vista/index.shtml).
We found a few blocks of conserved sequences within the 3.5-kb
second intron (data not shown). We constructed a reporter gene,
named Ci-Hox1(intron2)/lacZ, in which lacZwas fused downstream of
the ﬁrst 22 bp of the second exon (Fig. 1B). It contained a genomic
DNA fragment spanning from nucleotide position−894 (NruI site) to
the ﬁrst 11 bp of the translated region of Ci-Hox1 (Fig. 1B). It also
contained a 1.9-kb fragment, excised from the second intron with SalI
and XmnI (Fig. 1B). This fragment contained all the blocks of con-
served sequences. Since the intronic fragment did not contain the 5′
and 3′ splice sites, it was fused upstream of the 5′ ﬂanking region
(Fig. 1B). The transgene was introduced into one-cell embryos by
electroporation, and the expression of lacZ was visualized by the
histochemical staining of β-galactosidase activity (Fig. 1C). Ci-Hox1
(intron2)/lacZ was expressed in the epidermis and neural tube.
Epidermal expression was restricted to the posterior half of the trunk
and the anterior third of the tail in tailbud stage embryos (Fig. 1C). A
ﬂuorescent staining using a β-galactosidase-speciﬁc antibody
revealed that the expression in the neural tube was restricted to the
neck, visceral ganglion and anterior nerve cord regions (Fig. 1C'). This
pattern of expression was similar to that of endogenous Ci-Hox1,
although the expression domain of the reporter gene seemed slightly
wider than that of the endogenous gene (Nagatomo and Fujiwara,
2003). The expression of Ci-Hox1(intron2)/lacZwas activated by 1 μM
all-trans RA in the entire epidermis (Fig. 1E). DMSO, the solvent used
to make the stock solution of RA, did not affect the pattern of
expression of the reporter gene (Fig. 1D). The DNA fragment between
the SpeI site (nucleotide position−118) and BstBI site in the intronic
sequence was deleted from Ci-Hox1(intron2)/lacZ (Fig. 1B). The
resultant plasmid, named Ci-Hox1(ΔBsSp)/lacZ, lost 775 bp of the 5′
ﬂanking region and 41 bp of intronic sequence through this deletion
(Fig. 1B). The epidermal expression of Ci-Hox1(ΔBsSp)/lacZ was
much weaker than that of Ci-Hox1(intron2)/lacZ (Fig. 1F). In contrast,
the expression of Ci-Hox1(ΔBsSp)/lacZ in the neural tube was not
affected (Fig. 1F). Although RA enhanced the expression of Ci-Hox1
(ΔBsSp)/lacZ in the epidermis to some extent, the responsiveness to
RA was severely affected (Fig. 1G). The expression of Ci-Hox1
(ΔBsSp)/lacZ in the neural tube seemed slightly upregulated by RA
(Fig. 1G). However, this was not clear because the anterior neural
tube did not close and its constituent cells remained outside and
were not regularly arranged in the RA-treated embryo (Nagatomo et
al., 2003; Fig. 1G). The results suggest that the 5′ ﬂanking region
contains an enhancer element important for activation in the epider-
mis. We focused our attention mainly on this epidermal enhancer
element.
The epidermal enhancer of Ci-Hox1 is directly activated by RA
The response of the epidermal enhancer to RA was examined by
simultaneously treating electroporated embryos with 1 μM RA and
200 μg/ml of a translational inhibitor, puromycin. Drug treatmentwas
performed for 1 hour at the neurula stage just before the endogenous
Ci-Hox1 gene starts to be expressed. The expression of lacZmRNAwas
detected by in situ hybridization. Ci-Hox1(intron2)/lacZ was
expressed in the epidermis and neural tube in DMSO-treated control
embryos (Fig. 2A). All-trans RA activated the expression of Ci-Hox1
(intron2)/lacZ in all epidermal cells, irrespective of the presence of
puromycin (Figs. 2B and C). In contrast, RA did not activate the
expression of Ci-Hox1(ΔBsSp)/lacZ in the epidermal cells (Figs. 2D–F).
These results suggest that no protein synthesis is necessary for the RA-
dependent activation of the epidermal enhancer of Ci-Hox1. This
means that the RAR/RXR heterodimer binds and directly activates the
enhancer.
Fig. 2. Direct activation of the epidermal enhancer of Ci-Hox1 by RA. The expression of reporter genes was detected by whole-mount in situ hybridization. In all panels, the anterior
side of the embryo is oriented to the left, with the dorsal side up. ep, epidermis; nt, neural tube. Insets show similar expression patterns observed in multiple specimens. (A–C) The
pattern of expression of Ci-Hox1(intron2)/lacZ. (D–F) The pattern of expression of Ci-Hox1(ΔBsSp)/lacZ. (A and D) DMSO-treated embryos. (B and E) Embryos simultaneously
treated with RA and puromycin. (C and F) RA-treated embryos.
Fig. 3. Inhibition of RA synthesis affects the activity of the epidermal enhancer ofCi-Hox1. (A-D) Expression ofCi-Hox1(intron2)/lacZ in citral-treated embryos. (A) Ethanol-treated control
embryos. (B–D)Embryos treatedwith15 μM(B), 20 μM(C), or 30 μM(D)of citral. (E–H)ExpressionofCi-Hox1(intron2)/lacZ inDEAB-treatedembryos. (E)DMSO-treatedcontrol embryos.
(F–H) Embryos treated with 150 μM (F), 200 μM (G), or 250 μM (H) of DEAB. The expression of the reporter gene was detected by whole-mount in situ hybridization. In all panels, the
anterior side of the embryo is oriented to the left, with the dorsal side up. nt, neural tube. Insets show similar expression patterns observed in multiple specimens.
458 M. Kanda et al. / Developmental Biology 335 (2009) 454–463
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To investigate whether endogenous RA is necessary for the
activation of the epidermal enhancer of Ci-Hox1, we tested the effect
of inhibitors of RA synthesis (citral and DEAB) on the expression of Ci-
Hox1(intron2)/lacZ. Embryos carrying Ci-Hox1(intron2)/lacZ were
treatedwith citral or DEAB (Fig. 3). Citral affected retinal developmentFig. 4. Conserved sequence elements in the 5′ ﬂanking region of the Hox1 genes in two relat
intestinalis and C. savignyi by the Vista Genome Browser. The ﬁrst two exons of Ci-Hox1 are i
conserved regions are shown by a blue window (element 1) and an orange window (elemen
shaded in blue, while element 2 is in orange. A DR2-type RARE-like sequence is indicated by
the corresponding region of the C. savignyi genome (Cs-Hox1-element 2). The RARE-like sequ
the analysis summarized in Table 1. Names of transgenes are on the right. The mutagenize
transcription start site is indicated by an arrow. Two conserved sequence elements are indica
the Ci-Hox1 gene is indicated on the top. (E) Comparison of the RARE-like sequence (DR2-tin zebraﬁsh at 50–250 μM (Marsh-Armstrong et al., 1994). DEAB
caused speciﬁc morphogenetic defects in zebraﬁsh embryos at 50–
100 μM (Kopinke et al., 2006). Since these drugs have never been used
for ascidians, we treated the C. intestinalis embryo at various
concentrations. Citral and DEAB inhibited the expression of Ci-Hox1
(intron2)/lacZ in a dose-dependent manner (Fig. 3). The expression
was affected in both the epidermis and neural tube (Fig. 3). Theseed Ciona species. (A) Comparison of the 5′ ﬂanking region of Hox1 orthologs between C.
ndicated by blue boxes. The waveform represents the level of sequence similarity. Two
t 2). (B) Nucleotide sequence of a part of the 5′ ﬂanking region of Ci-Hox1. Element 1 is
a red box. (C) Alignment of nucleotide sequence of element 2 (Ci-Hox1-element 2) with
ence is indicated by a red box. (D) Diagrams show different 5′ ﬂanking regions used for
d site is indicated by a red cross. The exons of Ci-Hox1 are shown by gray boxes. The
ted by a blue oval (element 1) and an orange oval (element 2). The genomic structure of
ype RARE) and its mutagenized form (DR2-type RARE mut).
Table 1
The expression of Ci-Hox1 transgenes shown in Fig. 4D.
Expression patternTransgene name
Epidermis Epidermis and
ectopic
Ectopic No
expression
N
Ci-Hox1(0.9)/lacZ 28.1% 32.3% 18.8% 20.8% 96
Ci-Hox1(del1)/lacZ 27.0% 44.3% 27.0% 1.7% 115
Ci-Hox1(del2)/lacZ 0% 0% 84.2% 15.8% 57
Ci-Hox1(0.9)mut/
lacZ
0% 0% 96.3% 3.7% 82
460 M. Kanda et al. / Developmental Biology 335 (2009) 454–463results suggest that the activation of the Ci-Hox1 enhancer needs
endogenous RA. Since the development of citral-treated and DEAB-
treated embryos seemed to be delayed (Fig. 3), we examined the
expression of Ci-Hox1(intron2)/lacZ at later stages. However, the
expression was not activated in the later stage embryos (data not
shown).
An RARE-like sequence is necessary for the activity of the epidermal
enhancer of Ci-Hox1
The nucleotide sequence of the 5′ ﬂanking region of Ci-Hox1 was
compared with that of the C. savignyi Hox1 gene (Cs-Hox1), using the
VISTA Genome Browser (Fig. 4A). We found two blocks of conserved
sequences, named elements 1 and 2 (Fig. 4A). Element 2 contained a
sequence similar to the consensus RARE (Fig. 4B). Typical RARE
sequences are direct repeats of two half sites to which RAR and RXR
bind (Umesono et al., 1991). The half sites (5′-AGGTCA-3′ or
sequences similar to it) are usually separated by two or ﬁve nucleo-
tides. They are called DR2 and DR5, respectively. The complementary
strand of the RARE-like sequence in element 2 (5′-GGGTGAaa-
AGTTCA-3′) resembled DR2 (Fig. 4B). This nucleotide sequence was
completely conserved in the corresponding region of the C. savignyi
genome (Fig. 4C). To assess the activity of elements 1 and 2, we
constructed a reporter gene, where lacZ was placed downstream of a
genomic DNA fragment spanning from nucleotide position−853 (SalI
site) to the putative translation initiation site (Fig. 4D). The reporterFig. 5. The RARE-like sequence in the 5′ ﬂanking region of Ci-Hox1 is necessary for the a
mutagenized derivatives, named Ci-Hox1(intron2)mut/lacZ. The exons of Ci-Hox1 are indicat
site is indicated by a red cross. (B and C) The pattern of expression of Ci-Hox1(intron2)/lac
treated control embryos. (C and E) RA-treated embryos. In all panels, the anterior side of th
Insets show similar expression patterns observed in multiple specimens.gene, named Ci-Hox1(0.9)/lacZ, contained the elements 1 and 2
(Fig. 4D). It did not contain the intronic sequence. The expression of
Ci-Hox1(0.9)/lacZ was mainly observed in the epidermis (Fig. 4D,
Table 1). The epidermal expression was restricted to the posterior half
of the trunk and the anterior third of the tail region (data not shown).
This pattern of epidermal expressionwas similar to that obtainedwith
Ci-Hox1(intron2)/lacZ. However, no expression was observed in the
neural tube (Table 1). Considering the expression pattern of Ci-Hox1
(ΔBsSp)/lacZ, a neural tube enhancer is thought to be located within
the second intron (Figs. 1F and 2D).We generated an internal deletion
of element 1 or element 2 of Ci-Hox1(0.9)/lacZ (Fig. 4D). The pattern
of expression of Ci-Hox1(del1)/lacZ, which did not contain element 1,
was indistinguishable from that of Ci-Hox(0.9)/lacZ (Table 1). Ci-Hox1
(del2)/lacZ did not contain element 2 (Fig. 4D). No expression of lacZ
mRNA was observed in the epidermis of the embryo carrying Ci-Hox1
(del2)/lacZ (Table 1). Ci-Hox1(0.9)mut/lacZ contained point muta-
tions in the RARE-like sequence (Figs. 4D, E). The expression of Ci-
Hox1(0.9)mut/lacZwas not detected in the epidermis (Table 1). These
results indicate that the DR2-type RARE-like sequence in element 2 is
necessary for the activation of the epidermal enhancer of Ci-Hox1 in
normal embryos.
To conﬁrm that the RARE-like sequence in element 2 was
speciﬁcally required for the epidermal enhancer, we generated the
same mutation in Ci-Hox1(intron2)/lacZ (Fig. 5A). The resultant
reporter gene was named Ci-Hox1(intron2)mut/lacZ (Fig. 5A). As
described above, Ci-Hox1(intron2)/lacZ was expressed in the epider-
mis and neural tube (Fig. 5B; see also Figs. 1C, C', D). RA strongly
activated the expression of Ci-Hox1(intron2)/lacZ in the entire
epidermis (Fig. 5C; see also Fig. 1E). In contrast, Ci-Hox1(intron2)
mut/lacZ was expressed exclusively in the neural tube in normal
embryos (Fig. 5D). The expression in the neural tube served as an
internal control, indicating that the embryos carried a sufﬁcient
amount of transgenes. RA did not strongly induce the expression of Ci-
Hox1(intron2)mut/lacZ in the epidermis (Fig. 5E). Thus, the RARE-like
sequence in element 2 is important for the activation in the epidermis
of normal embryos and the responsiveness to RA. The results also
revealed that the RARE-like sequence is not required for the activation
of the neural tube enhancer.ctivity of the epidermal enhancer. (A) Diagrams show Ci-Hox1(intron2)/lacZ and its
ed by gray boxes. The transcription start site is indicated by an arrow. The mutagenized
Z. (D and E) The pattern of expression of Ci-Hox1(intron2)mut/lacZ. (B and D) DMSO-
e embryo is oriented to the left, with the dorsal side up. ep, epidermis; nt, neural tube.
Fig. 6. Electrophoretic mobility shift assay. Double-stranded 32P-labeled oligonucleotide probes (Ci-Hox1-DR2 and Ci-Hox1-DR2mut) were incubated with in vitro translated
proteins (Ci-RAR, Ci-RXR or TC14-3). DNA/protein complexes were fractioned on a polyacrylamide gel and visualized by scanning with a BAS-2500 IP Reader. Proteins, radiolabeled
probes, and competitors added to the reaction are indicated by (+) or (−) in each lane. Signals indicating DNA/protein complexes are indicated by an arrow. Arrowheads (NS)
indicate non-speciﬁc signals. Sequences of the probes are shown. Lower case letters indicate mutagenized nucleotides.
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We used an EMSA to test whether the RAR/RXR heterodimer binds
the putative DR2-type RARE of Ci-Hox1. In vitro synthesized Ci-RAR, Ci-
RXR and TC14-3 proteins were used for EMSA. TC14-3 was used as a
control protein. TC14-3 is a galactose-binding Ca2+-dependent lectin,
whose cDNA clone was isolated from the budding ascidian Polyandro-
carpa misakiensis (Matsumoto et al., 2001). An oligonucleotide probe
was designed to contain the putative RARE found in the 5′ ﬂanking
region of Ci-Hox1. The probe was called, Ci-Hox1-DR2. A DNA/protein
complex was formed when Ci-Hox1-DR2 was added to the reaction
mixture containing Ci-RAR and Ci-RXR (Fig. 6, lane 3). No shifted band
was observed when Ci-Hox1-DR2 was mixed with either Ci-RAR or
Ci-RXR only (Fig. 6, lanes 1 and 2). TC14-3 did not form a complex with
Ci-Hox1-DR2 (Fig. 6, lane 4). The complex's formation was inhibited
with a 50-fold molar excess of unlabeled CiHox1-DR2, but not with an
oligonucleotide containing anAP2-binding sequence (Fig. 6, lanes 6 and
7). Another probe, named Ci-Hox1-DR2mut, was prepared, which
contained point mutations within the putative RAR-binding sequence
of Ci-Hox1-DR2. Ci-Hox1-DR2mut did not form a complex with a
mixture of Ci-RAR and Ci-RXR proteins (Fig. 6, lane 5). The results
indicate that the DR2-like sequence in the 5′ ﬂanking region of Ci-Hox1
is a genuine RARE that binds the Ci-RAR/Ci-RXR heterodimer.
Discussion
Epidermal expression of Ci-Hox1 is activated by RA
In the present study, we identiﬁed an epidermal enhancer, lying
within the 5′ ﬂanking region of the Ci-Hox1 gene. We found an RARE
within the enhancer region. The Ci-RAR and Ci-RXR proteins bind this
RARE. Since neither of these proteins formed a protein/DNA complex,
Ci-RAR and Ci-RXR probably bind this sequence as a heterodimer.
Deletion or point mutation of the RARE sequence impaired the
enhancer activity, suggesting that the binding of Ci-RAR and Ci-RXR to
this sequence is necessary. This, in turn, suggests that the RA signal is
required to activate the epidermal enhancer of Ci-Hox1 in normal
embryos. This was supported by the results that the inhibition of RAsynthesis by citral and DEAB diminished the activity of the enhancer.
These ﬁndings are consistent with previous observations that RA
activated the expression of endogenous Ci-Hox1 gene even in the
presence of puromycin (Ishibashi et al., 2005). The present study
provides the ﬁrst direct evidence that ascidian RAR and RXR proteins
activate the enhancer of a target gene in response to the endogenous
RA signal. Since the larvacean, O. dioica, does not contain an RAR-
encoding gene in its genome, Cañestro and Postlethwait (2007)
suggested that an RAR-independent pathway (e.g. protein kinase
C-dependent signal transduction pathway) is involved in the response
of the Ci-Hox1 gene to RA. However, the input from Ci-RAR to Ci-Hox
has not been disconnected during the evolution of the ascidian lineage
of the chordates. The RA-independent mechanism of establishing the
tadpole-type larval body plan was possibly acquired as a derivative
feature in the larvacean ancestor.
Epidermis-speciﬁc function of the RARE
The Ci-Hox1(ΔBsSp)/lacZ reporter gene was expressed in the
neural tube, although this gene did not contain the RARE in the 5′
ﬂanking region. This result suggests that the RARE, found in the
present study, is not necessary for the activation of the neural tube
enhancer that is probably located within the second intron of the
Ci-Hox1 gene. However, Imai et al. (2009) showed that an Raldh2-
speciﬁc morpholino oligonucleotide suppressed the expression of Ci-
Hox1 in the neural tube. Correspondingly, the present study showed
that the expression of Ci-Hox1(intron2)/lacZ was also diminished in
the neural tube by citral and DEAB. The expression of Ci-Hox1
(ΔBsSp)/lacZ seemed slightly enhanced in the neural tube, although it
was difﬁcult to estimate the level of enhancement because of the
impaired arrangement of the neural tube cells in RA-treated embryos.
These observations could be explained by the existence of another
RARE within the neural tube enhancer. The 3′ ﬂanking region of the
murine Hoxb1 gene contains two RARE sequences (Marshall et al.,
1994; Huang et al., 1998). One of them is required for the expression
in the neural epithelium, and the other is responsible for the
expression in the foregut (Marshall et al., 1994; Huang et al., 1998).
Ogura and Evans (1995) revealed that two RARE sequences in the
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transcription factor-binding sites. Tissue-speciﬁc transcription factors
are thought to occupy either site and modulate the activity of the
RAR/RXR heterodimer, bringing about the tissue-speciﬁc function of
the RARE sequences (Ogura and Evans, 1995). The same binding site
for the Drosophila Dorsal protein mediates transcriptional activation
and repression in a context-dependent manner (Pan and Courey,
1992). It is therefore reasonable to think that another RARE is located
within the neural tube enhancer of Ci-Hox1, and mediates the neural
tube-speciﬁc function of the Ci-RAR/Ci-RXR heterodimer. Further
detailed analyses are necessary for characterization of the neural tube
enhancer of Ci-Hox1.
Another pathway of RA-dependent transactivation of Ci-Hox1 in the
epidermis
The Ci-Hox1(ΔBsSp)/lacZ reporter gene did not lose all sensitivity
to exogenously administered RA, even though it lacked the RARE.
However, the response of Ci-Hox1(ΔBsSp)/lacZ to RA was suppressed
by puromycin. These observations suggest that the regulatory region
of Ci-Hox1 contains another sequence element responsible for an
indirect response to RA. A plausible hypothesis is that the Ci-RAR/
Ci-RXR heterodimer activates the transcription of a gene X, whose
protein product activates the expression of Ci-Hox1. In this case,
puromycin can diminish the expression of Ci-Hox1 by inhibiting the
translation of the X mRNA. In vertebrates, cdx1 is a direct target of
RAR (Houle et al., 2000). The enhancer region of cdx1 contains an
RARE that is required for normal expression (Houle et al., 2000, 2003).
The spatial expression of various Hox genes is directly or indirectly
regulated by Cdx (Houle et al., 2003; Gaunt et al., 2004). Imai et al.
(2009) revealed that FGF8/17/18 activates the expression of Ci-Hox1
in the neck region of the neural tube. However, it is unclear whether
RA is involved in this genetic cascade (Imai et al., 2009).
Evolution of the epidermal enhancer of Hox1 in the chordates
Epidermal expression of Hox1 is also observed in the amphioxus
Branchiostoma ﬂoridae (Holland and Garcia-Fernàndez, 1996) and
the hemichordate Saccoglossus kowalevskii (Lowe et al., 2003).
Epidermal expression of Hox1 is a common feature of non-vertebrate
deuterostomes. RA is involved in the region-speciﬁc expression of the
amphioxus Hox1 (Schubert et al., 2004a). RA also affected the pattern
of expression of genes in epidermal sensory neurons (Schubert et al.,
2004a). Since epidermal sensory neurons in the C. intestinalis larva
show a well-organized spatial pattern (Takamura, 1998; Pasini et al.,
2006), it is of interest whether this pattern is regulated by Ci-RAR and
Ci-Hox1.
The epidermal expression of Hox1 is regulated by RA in B. ﬂoridae
(Schubert et al., 2004a). The present ﬁnding that the epidermal
expression of Hox1 is also regulated by RA during Ciona embryogen-
esis, strongly supports the homology of Hox1's epidermal expression
between ascidian and amphioxus. Because Hox1 is also expressed in
the epidermis of S. kowalevskii, the expression of Hox1 in the
epidermis likely predates the evolution of the neural tube (Lowe
et al., 2003). We provide evidence that in Ciona, the neural tube
expression of Hox1 is regulated by a cis-regulatory element distinct
from that for the epidermis, although both are dependent on RA. Thus,
the expression of Hox1 in the chordate neural tube was probably
made possible by novel cis-regulatory elements. In vertebrates, Hox
gene expression is also observed in somitic and lateral plate
mesoderm. The new Hox code in the mesoderm may have also been
acquired through new cis-regulatory elements. The elaborated body
plan of vertebrates may have been established by this sequential co-
opting of the Hox code.
In this respect, it is of interest how the regulatory mechanism for
the epidermal expression of Hox is retained in vertebrates. Epidermalexpression of vertebrate Hox1 is observed in the pharyngeal region.
The epidermal cells play essential roles in the patterning of the
vertebrate pharynx, where Hox genes might be involved. Alternative-
ly, the epidermal expression might be co-opted to the Hox code in the
vertebrate neural crest, whose development is regulated by inter-
action between the neural tube and epidermis. AP-2 is the only
transcription factor proved to be speciﬁcally involved in the neural
crest expression of the vertebrate Hox genes. AP-2 is expressed in the
entire epidermis in both ascidian and amphioxus. The present study
suggested that an epidermis-speciﬁc co-factor activates the epidermal
enhancer of Ci-Hox1 synergistically with the RAR/RXR heterodimer.
AP-2 is a candidate for this co-factor, although it remains to be
elucidated whether AP-2 is involved in the expression of Hox1 in the
epidermis. Identiﬁcation of the ascidian epidermal factor cooperating
with the RAR/RXR heterodimer will clarify the evolutionary history of
the epidermal Hox code, and its contribution to the evolution of the
vertebrate body plan.
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